Ultragenyx Pharmaceutical Inc banner

Ultragenyx Pharmaceutical Inc
LSE:0LIF

Watchlist Manager
Ultragenyx Pharmaceutical Inc Logo
Ultragenyx Pharmaceutical Inc
LSE:0LIF
Watchlist
Price: 27.85 USD 1.45% Market Closed
Market Cap: $2.7B

Intrinsic Value

The intrinsic value for Ultragenyx Pharmaceutical Inc (0LIF) under the Base Case is 44.31 USD. Compared with the current market price of 27.85 USD, the stock appears Undervalued by 37% .

Based on two methods:

DCF suggests overvaluation, while multiples suggest undervaluation.

0LIF Intrinsic Value
44.31 USD
Undervaluation 37%
Intrinsic Value
Price $27.85
Bear Case
Base Case
Bull Case
Monitor 0LIF
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value $35.45
Get notified when the price drops into your buy zone
Intrinsic Value $44.31
Margin of Safety 20% $35.45
Current Price $27.85
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about 0LIF?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is 0LIF valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Ultragenyx Pharmaceutical Inc.

Explain Valuation
Alternatives to 0LIF

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

RARE Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one 0LIF stock?

The intrinsic value for Ultragenyx Pharmaceutical Inc (0LIF) under the Base Case is 44.31 USD.

Is 0LIF stock undervalued or overvalued?

Compared with the current market price of 27.85 USD, the stock appears Undervalued by 37% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett